pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·1h ago·1 min read
save

STAT reporters outline how upcoming midterms could reshape US vaccine, drug policy and the MAHA movement

Oct 30, 2026·read at STAT ↗Neutral

STAT's weekly video series STATus Report aired from Boston, the historic heart of American democracy, as the nation heads toward the midterm elections. The episode features reporters from the D.C. bureau and across the newsroom discussing how the vote could affect federal health and science policy.

The team examined possible shifts in vaccine policy, drug regulation and the growing MAHA movement, noting that election outcomes may influence funding, approval pathways and public health initiatives.

The segment also included excerpts from an interview with Michigan Senate candidate Abdul El-Sayed. He responded to recent remarks by RFK Jr. about Arab Americans in health and science and outlined the public-health objectives he would pursue if elected.

Overall, the discussion highlights the uncertainty facing pharma professionals and investors as political dynamics shape the regulatory environment.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “The health care issues STAT reporters are watching in the midterms”

read at STAT ↗
331 words · retrieved 16m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoSTAT+: How a simple UTI turns into a $1,756 billSTAT
  • 1h agoOpinion: How Congress can fix expert advisory committeesSTAT
  • 1h agoSTAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settingsSTAT
  • 1h agoOpinion: What a mother’s 1834 letter about measles tells us about MAHASTAT
  • 14h agoSTAT+: Federal judge rejects new Medicaid ‘frailty’ definition for work requirementsSTAT